- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 95
Corporate venturing deal net: 23-27 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 27, 2020Letgo links to OfferUp in merger deal
Naspers subsidiary OLX Group led a $120m round for the e-commerce app developers, which have agreed to merge, and will own 40% of the combined entity.
Mar 26, 2020ZEG Power digs up funding
CCB and CO2 Management came onboard in an $11.3m round for ZEG as it continutes work on its clean hydrogen generation facility.
Mar 25, 2020City Developments helps build Pupil's funding
Pupil, developer of a spatial analysis system for real estate, raised $16.1m in a round led by property developer City Developments that will fund product development.
Mar 25, 2020Ping An picks out iCapital in $146m round
The asset management software producer has closed a round led by Ping An Global Voyager Fund with contributions from Goldman Sachs, UBS and BNY Mellon.
Mar 24, 2020Cazoo motors to $117m
Online used car retailer Cazoo took its overall funding to approximately $218m in a round led by corporate venturing vehicle DMG Ventures.
Mar 24, 2020Dragonfly Therapeutics drags financing to $300m
Celgene-backed immuno-oncology drug developer Dragonfly Therapeutics boosted its total financing to $300m in round of undisclosed size led by Fidelity.
Mar 24, 2020Nurix nabs $120m
Celgene-backed Nurix Therapeutics will use the capital to advance two protein modulation-based immuno-oncology drug candidates toward clinical trials.
Mar 23, 2020Corporate venturing deal net: 16-20 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 20, 2020RemeGen retrieves $100m
The antibody therapy developer closed a $100m round co-led by Lilly Asia Ventures that will fund phase 3 clinical studies for its lead drug candidates.
Mar 18, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


